(R)-tert-Butyl (1-benzylpyrrolidin-3-yl)carbamate

Catalog No. :
ACCHNR867
CAS No. :
131878-23-4
Molecular Formula :
C16H24N2O2
Molecular Weight :
276.38

IUPAC Name:tert-butyl (R)-(1-benzylpyrrolidin-3-yl)carbamate

(R)-tert-Butyl (1-benzylpyrrolidin-3-yl)carbamate structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
100g95%$83.00Login to see priceIn stockInquiry
500g95%$339.00Login to see priceInquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name(R)-tert-Butyl (1-benzylpyrrolidin-3-yl)carbamate
IUPAC Nametert-butyl (R)-(1-benzylpyrrolidin-3-yl)carbamate
MDL No.MFCD01321148
Molecular FormulaC16H24N2O2
Molecular Weight276.38
SMILESO=C(OC(C)(C)C)N[C@H]1CN(CC2=CC=CC=C2)CC1
InChI KeyPHOIDJGLYWEUEK-CQSZACIVSA-N
Synonym(R)-1-Benzyl-3-(Boc-amino)pyrrolidine | tert-butyl N-[(3R)-1-benzylpyrrolidin-3-yl]carbamate | (R)-(+)-1-Benzyl-3-(Boc-amino)pyrrolidine, 97% | DS-1375 | MFCD01321148 | tert-Butyl [(3R)-1-benzylpyrrolidin-3-yl]carbamate | (R)-tert-Butyl (1-benzylpyrrolidi
CAS No.131878-23-4
PubChem CID10286119

Safety Data

Pictogram
Harmful or irritant
Signal Word
Achtung
Hazard Statement(s)
H315-H319-H335
Precautionary Statement(s)
P261-P305+P351+P338

Synthetic Route by SureRoute

1. ACCHNR867 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACBZXE159 route compound structure diagram
    ACBZXE1591416450-63-9 In Stock
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACCHNR867 route product structure diagram
    ACCHNR867131878-23-4 In Stock
Inquiry

2. ACCHNR867 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. ACJAIQ912 route compound structure diagram
    ACJAIQ912114715-39-8 In Stock
  4. Then
  5. ACCHNR867 route product structure diagram
    ACCHNR867131878-23-4 In Stock
Inquiry

Comments (0)